Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
Cancer Biotherapy and Radiopharmaceuticals · 2024
DOI: 10.1089/cbr.2023.0199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Li Hua und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the Forth Affiliated Hospital of Guangxi Medical University, Liuzhou, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Nomograms, Chemoradiotherapy, Neoplasm Staging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, the Forth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
ORCID-Profile: Mengzhuan Wei
Zitieren
APA
Hua, L., Wei, M., Feng, C., Li, S., Wen, X., & Chen, S. (2024). Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0199
Vancouver
Hua L, Wei M, Feng C, Li S, Wen X, Chen S. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0199
BibTeX
@article{Hua2024,
author = {Hua, Li and Wei, Mengzhuan and Feng, Chengjun and Li, Shiting and Wen, Xiaomin and Chen, Shaojun},
title = {Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2024},
doi = {10.1089/cbr.2023.0199}
}
EUVIMED